Last 3 July, we held the 6th edition of our joint workshop “Data and AI in healthcare, welcome to reality!”, organized in Brussels in close partnership with our associate member Relyens.
From diagnosis and personalized treatment to medical research and system efficiency, digital technologies and AI hold immense potential. But how do we navigate the ethical, data protection, and implementation challenges to ensure real-world benefits?
With contributions from European and International experts and the World Health Organization (WHO), we dived into concrete case studies and key discussions shaping the future of AI and Big Data in healthcare.
We started with two high-level speakers from the European Commission, Mrs Saila Rinne – Head of Unit at DG CNECT and Mr Yiannos Tolias – Legal lead on AI & AI liability at DG SANTE. They gave us a comprehensive overview of the regulatory framework for generative AI in EU, an update on the Commission’s initiatives a funding opportunities on AI as well as the presentation of the preliminary findings of the Commission’s study on the deployment of AI in health.
After the EU Commission, we heard from two different stakeholders, Ms Das from CPME, the Comité Permanent des Medicins Européens and Mr Petracca from Cergas Research Center, Bocconi University in Italy, bringing the perspective of the professionals and the researchers to the discussion.
We ended the morning with a session on insurance and medical-legal liability with two speakers, Dr Lolfing from Bird & Bird and Mrs Curtit from Relyens.
In the afternoon, we welcomed Mr Keyrellous Adib from WHO Regional Office for Europe. His participation brought invaluable expertise to our discussions on how digital innovation can drive better, safer, and more equitable healthcare across Europe. As AI continues to transform the health sector, collaboration with international organizations like WHO ensures we keep patient care, ethics, and public health at the center of innovation.
We then shifted perspective and introduced a session on concrete cases of deployment of AI in EU countries with Mr Bruski from the Polish association of Private Hospitals and Mr Gruson from Ethik-IA. We ended this session with Mrs Catillon from Analysis Group, who delivered a comprehensive and very rich presentation on EU and US regulation on AI in health.
It was indeed an insightful workshop exploring the promise and reality of Big Data and AI in healthcare. A sincere thank you to all our speakers and participants for contributing to this crucial dialogue.
